Cargando…
Clinico-biological features of T-cell acute lymphoblastic leukemia with fusion proteins
T-cell acute lymphoblastic leukemias (T-ALL) represent 15% of pediatric and 25% of adult ALL. Since they have a particularly poor outcome in relapsed/refractory cases, identifying prognosis factors at diagnosis is crucial to adapting treatment for high-risk patients. Unlike acute myeloid leukemia an...
Autores principales: | Steimlé, Thomas, Dourthe, Marie-Emilie, Alcantara, Marion, Touzart, Aurore, Simonin, Mathieu, Mondesir, Johanna, Lhermitte, Ludovic, Bond, Jonathan, Graux, Carlos, Grardel, Nathalie, Cayuela, Jean-Michel, Arnoux, Isabelle, Gandemer, Virginie, Balsat, Marie, Vey, Norbert, Macintyre, Elizabeth, Ifrah, Norbert, Dombret, Hervé, Petit, Arnaud, Baruchel, André, Ruminy, Philippe, Boissel, Nicolas, Asnafi, Vahid |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8791998/ https://www.ncbi.nlm.nih.gov/pubmed/35082269 http://dx.doi.org/10.1038/s41408-022-00613-9 |
Ejemplares similares
-
Oncogenetic landscape and clinical impact of IDH1 and IDH2 mutations in T-ALL
por: Simonin, Mathieu, et al.
Publicado: (2021) -
TREC mediated oncogenesis in human immature T lymphoid malignancies preferentially involves ZFP36L2
por: Balducci, Estelle, et al.
Publicado: (2023) -
Impact of T-cell Receptor Status on Mutational Landscape and Outcome in T-ALL
por: Dourthe, Marie Emilie, et al.
Publicado: (2023) -
Harnessing the MYB-dependent TAL1 5’super-enhancer for targeted therapy in T-ALL
por: Smith, Charlotte, et al.
Publicado: (2023) -
Low level CpG island promoter methylation predicts a poor outcome in adult T-cell acute lymphoblastic leukemia
por: Touzart, Aurore, et al.
Publicado: (2020)